25 research outputs found

    Exercise and Quality of Life

    No full text
    Exercise is a fundamental intervention for any patient with diabetes or at risk for it. Exercise not only contributes to the control of blood glucose but also reduces the risk of metabolic abnormalities and diabetes-related complications and comorbidities. Despite the growing prevalence of diabetes in the world, most people are not as physically active as guidelines and evidence recommend. In this chapter, we focus on the topic of exercise and quality of life, briefly addressing quality of life assessment in patients with diabetes. In addition, given the strong association of depression with diabetes and its impact on quality of life, we also cover the potential benefits of exercise interventions in the setting of diabetes and depression. While most studies show evidence of short- and long-term exercise interventions, there are still several areas that require further research. Moreover, the impact from exercise in older adults requires additional attention, given the aging of the population and because older people may have long-standing disease, with greater prevalence of its complications, as well as greater prevalence of multimorbidity, which will also impact their quality of life

    A new angle for glp-1 receptor agonist: the medical economics argument Editorial on: Huetson P, Palmer JL, Levorsen A, et al. Cost-effectiveness of the once-daily glp-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway. J Med Econ 2015: 1-13 [Epub ahead of print]

    No full text
    Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are relatively new medications for diabetes that offer a weight-loss profile that can be considered desirable for patients with both type 2 diabetes (T2D) and obesity. GLP-1 RA are effective in combination with insulin, and even slightly superior or at least equal to short-acting insulin in T2D; however, since they work in the incretin system, they may not be effective in long-standing disease. Additionally, only recently have publications reported their cardiovascular safety, and there is limited evidence for long-term effectiveness. The work presented by Huetson et al. offers a much needed perspective through a medical economic model for the long term cost-effectiveness of GLP-1 RA. The authors found benefits in quality-adjusted life years and reduced lifetime healthcare costs. While there are a few limitations, this study contributes to the understanding of these agents and their impact on the epidemics of obesity in T2D, where weight management is no longer an option, but an essential component of the diabetes plan of care

    Assessment procedures including comprehensive geriatric assessment

    No full text
    Geriatrics syndromes are more common in older adults with diabetes therefore their clinical management must incorporate comprehensive geriatric assessment (CGA) in the already well‐established comprehensive diabetes evaluation (CDE). This chapter explores the geriatrics approach to diabetes in older people, highlighting the relevance of screening for geriatric syndromes through a tailored CGA and patient‐centered management of diabetes in older people. Within the functional domain falls, impaired mobility, functional decline, vision loss, and hearing loss are among the most common geriatric syndromes. To explore this domain, the chapter briefly reviews the topic of falls. In the psychological/mental domain, depression, delirium, and dementia are common geriatric syndromes. Personality disorders and addictions are increasing in prevalence in this age group. To explore this domain, the chapter analyzes the impact of cognitive decline/dementia syndromes on diabetes. Long‐standing complications of diabetes should be reviewed and this is recommended in all patients with diabetes

    Recognizing the Needs of High-Need High-Risk Veterans

    No full text
    Understanding the needs of higher-risk older adult patients can support the delivery of high quality and patient-centered healthcare. We sought to characterize the physical, functional, social and psychological needs of High-Need High-Risk (HNHR) Veterans. We hypothesized that the concept of frailty could be useful in identifying the highest-risk HNHR patients and characterizing their needs. We conducted a cross-sectional study of Veterans in the Miami Veterans Affairs Healthcare System who were identified as High-Need High-Risk by the Department of Veterans Affairs (VA) using data analytic techniques. We analyzed data of 634 Veterans who completed questionnaires by mail, telephone or in person. We assessed the Veterans' frailty status and needs in the physical, functional, psychological and social domains. Beyond descriptive statistics, we used Chi-square ( ) test, one-way ANOVA and Kruskal-Wallis to analyze whether there were differences in Veterans' needs in relation to frailty status. The HNHR Veterans who participated in the questionnaire had complex needs that spanned the physical, functional, psychological, and social domains. We observed a potential mismatch between functional needs and social support; over two-thirds of respondents endorsed having dependence in at least one ADL but only about a third of respondents reported having a caregiver. Patients with frailty had higher levels of functional dependence and were more likely than the other HNHR respondents to report recent falls, recent hospitalizations, depression, and transportation issues. High-Need High-Risk Veterans have complex needs related to the physical, functional, psychological and social domains. Within the HNHR population, HNHR Veterans with frailty appear to have particularly high levels of risk and multidomain needs. Increased attention to identifying members of these groups and aligning them with biopsychosocial interventions that are targeted to their specific needs may support development of appropriate strategies and care-models to support HNHR Veterans
    corecore